You just read:

Dr. Nalini Rajamannan Comments on FDA Congressional Letter to Senate Finance Committee After Kaiser Health News Reveals Access to Exempt FDA Database

News provided by

Most Sacred Heart of Jesus Cardiology and Valvular Institute

06 Jan, 2020, 16:30 IST